Rebound hypercalcaemia timing is associated with cumulative weight-based denosumab dose for central giant cell granuloma treatment in children despite a dose weaning regimen
Titel:
Rebound hypercalcaemia timing is associated with cumulative weight-based denosumab dose for central giant cell granuloma treatment in children despite a dose weaning regimen
Auteur:
Chesover, Alexander D. Allgrove, Jeremy Calder, Alistair Campbell, Catherine Heffernan, Emmeline Mankad, Kshitij McBayDoherty, Rhiannon McKenna, Dearbhla Mills, Caroline Rooney, Madeline Saeed, Nadeem